Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033599 · ClinicalTrials.gov registry record · Phase 3
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
A Phase 3 study of Opioid Use and Tobacco Use, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 420
- Enrollment target
- 2
- Study locations
NCT06033599: Recruiting Phase 3 study of Opioid Use and Tobacco Use, sponsored by Rutgers, The State University of New Jersey.
NCT06033599 is a Phase 3 study of Opioid Use and Tobacco Use that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 420 participants, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033599, a Phase 3 study of Opioid Use and Tobacco Use, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 420 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Primary Outcome
Number of days of drug use as measured by self-reported days of use and biochemically verified use via drug screen.
Conditions Studied
Interventions
- OTHER MORE and MI and NRT
- OTHER MORE and No MI and NRT
- OTHER Support Group and MI and NRT
- OTHER Support Group and No MI and NRT
Study Locations (2)
New Jersey
- Rutgers Robert Wood Johnson Medical School - New Brunswick
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 3 |
What NCT06033599 shows while recruiting
NCT06033599 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 4 interventions - of which MORE and MI and NRT is the first listed.
NCT06033599 reports a single indexed study location in New Jersey, Utah.
Frequently Asked Questions
What is clinical trial NCT06033599 about?
NCT06033599 is a clinical study titled "Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement". The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, ...
What is the current status of trial NCT06033599?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 420 participants. The study started on 2023-09-05. Estimated completion is 2027-06-30.
What conditions does trial NCT06033599 study?
This clinical trial studies the following conditions: Opioid Use, Tobacco Use, Polysubstance Abuse.
What interventions are being tested in trial NCT06033599?
The interventions under investigation include: MORE and MI and NRT (OTHER), MORE and No MI and NRT (OTHER), Support Group and MI and NRT (OTHER), Support Group and No MI and NRT (OTHER).
Who is sponsoring clinical trial NCT06033599?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033599 being conducted?
This trial has 2 study locations across New Jersey, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06033599's enrollment target sits among peer trials
420 24th of 105 higher than 82 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Treating Polysubstance Use Using a Novel Digital Technology
RECRUITING · Phase 3
-
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Opioid Analgesic Reduction Study
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI